InterMune, Inc. (ITMN) Reports Q2 Miss
Tweet
Share
E-mailGet Alerts ITMN Hot Sheet
Price: $73.89 --0%
Financial Fact:
Research and development: 39.75M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 39.75M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
InterMune, Inc. (NASDAQ: ITMN) reported Q2 EPS of ($0.78), $0.55 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.54 million versus the consensus estimate of $39.99 million.
For earnings history and earnings-related data on InterMune, Inc. (ITMN) click here.
For earnings history and earnings-related data on InterMune, Inc. (ITMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- BK Technologies (BKTI) Tops Q2 EPS by 11c
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
